Podcast 94: What does a new meta-analysis tell us about statins and primary prevention?

A meta-analysis of 11 studies encompassing more than 60,000 subjects finds that statins don’t lower all-cause mortality in people without cardiovascular disease. One editorialist calls the study, just published in the Archives of Internal Medicine, “the cleanest and most complete meta-analysis of pharmacological lipid lowering for primary prevention.”

One of the study’s principal authors, Kausik K. Ray, talked with us from London. I think you’ll find that listening in is worth your time.

Interview-related links:

• Physician’s First Watch coverage of the Archives‘s statin papers
• Ray et al.‘s meta-analysis

News-related links:

• Starting dialysis early doesn’t improve mortality
• Digoxin’s dangers in dialysis
• Rosiglitazone’s bad week
• Tight glucose control in diabetes brings some benefits, but at the cost of “imprudent” risks
• PSA testing for prostate cancer lowers mortality, but mostly in low-screening regions

The post Podcast 94: What does a new meta-analysis tell us about statins and primary prevention? first appeared on Clinical Conversations.